Hindustan Unilever acquires Glenmark female hygiene brand VWash
HUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide, the company said.
New Delhi: Leading FMCG player Hindustan Unilever (HUL) on Friday said it has completed the acquisition of VWash from pharma major Glenmark Pharmaceuticals.
The company, however, did not disclose the value of the transaction.
The acquisition was announced in March and was subject to certain closing conditions, which have now been fulfilled, the FMCG firm said in a filing to BSE.
VWash was launched by Glenmark in 2013 and the brand has established itself as the market leader in the female intimate hygiene category backed by strong product proposition, consumer endorsements and brand-building investments.
HUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide, the company said.
"VWash acquisition is strategic and gives us an entry into a rapidly growing female intimate hygiene segment. It enables us to serve consumer needs through scientific solutions. This acquisition is also timely given heightened focus on health and hygiene," HUL Chairman and Managing Director Sanjiv Mehta said.
With this acquisition, HUL is looking to scale up the brand by building awareness, driving penetration, leveraging distribution and enhance the offering for chemist channel.
Read also: GSK moves to sell $3.45 billion stake in Hindustan Unilever in open market
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.